About
William H. Rastetter is a veteran biotech executive, scientist, and board chairman best known for leading IDEC Pharmaceuticals, later serving as executive chairman of Biogen Idec, and chairing multiple public biotech companies. He currently chairs Fate Therapeutics, Neurocrine Biosciences, and Daré Bioscience, and has also been associated with Illumina, Receptos, GRAIL, Regulus, and Iambic. He has documented direct investment activity in biotech companies and retains meaningful public-equity holdings.
Areas of interest
biotechtherapeuticsoncologyimmunologygenomicsneurologywomen's healthdrug developmentscientific company formationboard governance